May 8, 2024 03:58 AM EDTUpdated 06:28 AM
R&D
Pharma
Coronavirus

As­traZeneca pulls Covid-19 vac­cine glob­al­ly as the phar­ma sees 'no fu­ture com­mer­cial de­mand'

Kyle LaHucik

Senior Reporter

As­traZeneca is with­draw­ing its Ox­ford-col­lab­o­rat­ed Covid-19 vac­cine from glob­al mar­kets, the UK-based phar­ma com­pa­ny con­firmed in a state­ment to End­points News on Tues­day.

The spokesper­son …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

FDA vac­cine chief Pe­ter Marks pledges to stay as long as he's wel­come

Am­gen names Stan­ford ge­neti­cist and biotech founder to CSO post

Jazz wins ap­proval for bis­pe­cif­ic in bil­iary tract can­cer

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times